Apollo Hospitals successfully hosted ASPIRE 2025 (Apollo Symposium on Pulmonary Interventions and Respiratory Excellence) in ...

With $75.1 million in cash and minimal competition, aTyr Pharma is well-positioned financially, making it a compelling ...

The following is a summary of "Supplemental oxygen therapy use among patients with fibrosing interstitial lung disease in the United States," published in the February 2025 issue of the Respiratory ...

Gossamer Bio, Inc. (Nasdaq: GOSS), a late-stage, clinical biopharmaceutical company focused on the development and ...

Qureight and Remedy Cell have collaborated to validate the mechanism of action of RC-0315 in the Phase Ib clinical trial for ...

Most online pulmonary rehabilitation videos are understandable but lack key disease-specific information for conditions other than COPD.

An ex-RAF nurse has said that the detection of her rare disease was all thanks to an accidental collision with her family's ...

An ex-RAF nurse has said that the detection of her rare disease was all thanks to an accidental collision with her family's ...

A former RAF nurse claims her family's dog inadvertently led to her diagnosis with a rare lung disease. Pat Gildea was ...

University of Virginia School of Medicine scientists have discovered how severe COVID-19 can destroy immune cells' ability to repair the lungs, helping explain the lingering effects of long COVID.

University of Virginia School of Medicine scientists have discovered how severe COVID-19 can destroy immune cells' ability to ...

Iguratimod (IGU) is a disease-modifying anti-rheumatic drug (DMARD) that treats rheumatoid arthritis (RA) and other ...